Lancôme positions longevity as luxury skin care’s next frontier

Lancôme has entered a new phase of its longevity-in-beauty ethos through a partnership with Timeline, a Swiss longevity biotech startup.

The cosmetics heritage giant’s parent company, L’Oréal Group, began investing in Timeline in 2024 to centralize longevity in the global cosmetics industry. As the group’s investment ripens alongside the rapidly growing longevity discourse in the industry, Lancôme is bringing this partnership into the spotlight with a new skin care range.

The range is the first in the industry to contain Mitopure, a proprietary molecule proven to re-energize mitochondria through mitophagy — a cellular renewal process. The molecule is backed by over US$50 million in R&D and 15 years of research.

Personal Care Insights sits down with Vania Lacascade, global brand president of Lancôme, to discuss how the launch signals a new era for longevity-inspired beauty amid shifting consumer attitudes.

How does the new range influence Lancôme’s position in the skin care market?

Lacascade: The new range reinforces Lancôme’s leadership in the scientific territory of longevity. For us, longevity is not a trend — it is a frontier of progress reshaping how we understand aging and how to live a healthier, longer life.

With this partnership, Lancôme moves beyond correcting visible signs of age toward acting on the biological mechanisms that influence skin vitality over time. The new range reinforces our position as a powerhouse of progress and allows us to go deeper into the biological foundations of longevity.

The brand positions longevity as the future of skin care.

What differentiates Lancôme and Timeline’s products from other anti-aging products?

Lacascade: The key difference lies in how we approach aging itself and the biological depth of our approach. Mitopure, Timeline’s proprietary form of Urolithin A, has been clinically proven to re-energize mitochondria and activate mitophagy, the cell’s natural recycling process.

But we didn’t just integrate an ingredient; we developed proprietary formulas, delivery systems, and synergistic complexes where Mitopure works in synergy with Lancôme’s proprietary compounds, designed specifically for the biology of the skin. Timeline brings the longevity molecule. Lancôme brings the skin care authority and expertise, patents, data, and a deep scientific understanding of skin.

How do you anticipate this partnership evolving over time, especially amid shifts in consumer demand?

Lacascade: In 2024, L’Oréal Groupe invested in Timeline, becoming one of the first players to position beauty at the heart of the global longevity conversation. Today, Lancôme is the first brand within the group to exclusively turn this investment into a concrete longevity skin care collaboration. We are building an open-innovation strategy, and our goal is to actively build an avant-garde ecosystem by partnering with the most advanced scientific pioneers.

What do you attribute the rise in demand for biologically backed longevity products to?

Lacascade: We are witnessing a global cultural shift to ‘live better, not just longer.’ Longevity is no longer a niche scientific conversation — it is a societal reality that questions our relationship with age and how we approach vitality.

At Lancôme, we are moving from reactive correction to proactive, data-driven care. It’s no longer only about correcting visible signs, but about acting on fundamental biological processes to preserve and restore skin health span. Longevity isn’t a trend for us, it’s a scientific reality. When grounded in data, patents, and clinical validation, it provides a framework rooted in biology, not just aesthetics.

Do you see a shift in consumer attitudes towards aging itself? 

Lacascade: Women have moved from ‘fighting’ age to owning it. They no longer want to look younger ‘at all costs,’ they want to feel and look like the best version of themselves at every stage of life — with strong, healthy, luminous skin and a deep sense of confidence.

Aging is less a problem to hide and more a journey to manage proactively, with science, choice, and self-respect. The rise of longevity reinforces this shift. It moves us from a reactive anti-aging mindset to a proactive, integrative approach by anticipating and delaying the first signs of aging, intercepting early signs and slowing their progression, and resetting established signs.

What insights do you have on the demand for science-backed skin care vs. holistic, natural remedies in the longevity space?

Lancôme’s formula features Timeline’s clinically backed Mitopure molecule.

Lacascade: Longevity-washing happens when there is a story without data. At Lancôme, we have the data, the patents, and the clinical validation — and that credibility is essential in this space.

What truly differentiates Lancôme is our ability to translate scientific progress into daily longevity beauty products, combining real scientific breakthroughs with high sensorial, luxury skincare.

What does your launch signal about the future of the beauty and skin care industry, particularly around the concept of longevity?

Lacascade: The launch signals a new era for beauty. Longevity doesn’t replace anti-aging. It extends it with a longer-term, science-led approach to skin vitality. It represents an evolution enabled by advances in skin biology and aging research, allowing us to act earlier and more proactively on the biological mechanisms that influence skin vitality over time.

Our heart is, and will always be, beauty — beauty grounded in science. What we are introducing is a long-term, data-driven approach designed to help skin behave more youthful and resilient over time. We are not becoming a pharmaceutical brand — we are becoming a powerhouse of progress in skin science.